JHL Capital Group’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-60,000	Closed	-$1.22M	–	13
2016 Q4	$1.22M	Buy	+60,000	New	+$1.22M	0.09%	8